{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:53:34Z","timestamp":1793044414760,"version":"4.5.0"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:p>Uterine surgery is a common predisposing factor for uterine rupture, while an invasive mole that leads to uterine rupture is a rare clinical occurrence. Here, we report a case of a 31-year-old childless woman who underwent abortion after 53 days of pregnancy. She still experienced abdominal pain and scanty vaginal bleeding after the abortion. Her levels of human chorionic gonadotropin (HCG) were high, while ultrasound and MRI results revealed an enlarged uterus and a mass in the myometrium. During preparation for treatment, the gynecologist ruptured the uterus of the patient, leaving her shocked. Eventually the patient's uterus was removed the uterus and pathologically diagnosed as result is the an invasive mole.<\/jats:p>","DOI":"10.3389\/fsurg.2021.798640","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T05:06:11Z","timestamp":1643346371000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Invasive Mole Resulting in Uterine Rupture: A Case Report"],"prefix":"10.3389","volume":"8","author":[{"given":"Anshan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","article-title":"Gestational trophoblastic disease","volume":"376","author":"Seckl","year":"2010","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ygyno.2016.08.330","article-title":"15years of progress in gestational trophoblastic disease Scoring, standardization, and salvage","volume":"144","author":"Brown","year":"2017","journal-title":"Gynecol Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"vi39","DOI":"10.1093\/annonc\/mdt345","article-title":"Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Seckl","year":"2013","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.crad.2005.12.003","article-title":"Radiology of gestational trophoblastic neoplasia","volume":"61","author":"Allen","year":"2006","journal-title":"Clin Radiol"},{"key":"B5","first-page":"842","article-title":"Intrapartum uterine rupture in a primiparous patient previously treated for invasive mole","volume":"83","author":"Kaczmarek","year":"1994","journal-title":"Obstet Gynecol."},{"key":"B6","year":"2000"},{"key":"B7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole","volume":"203","author":"Lurain","year":"2010","journal-title":"Am J Obstet Gynecol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1200\/JCO.2012.43.1817","article-title":"EMA\/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis","volume":"31","author":"Alifrangis","year":"2013","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12885-018-5168-x","article-title":"Total hysterectomy versus uterine evacuation for preventing post-molar gestational trophoblastic neoplasia in patients who are at least 40 years old: a systematic review and meta-analysis","volume":"19","author":"Zhao","year":"2019","journal-title":"BMC Cancer."},{"key":"B10","doi-asserted-by":"publisher","first-page":"CD007289","DOI":"10.1002\/14651858.CD007289.pub3","article-title":"Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia","volume":"9","author":"Wang","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.6004\/jnccn.2019.0100","article-title":"Gestational trophoblastic Neoplasia, version 2.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Abu-Rustum","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"B12","doi-asserted-by":"publisher","first-page":"43368","DOI":"10.18632\/oncotarget.14727","article-title":"Fertility-sparing uterine lesion resection for young women with gestational trophoblastic neoplasias: single institution experience","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e17565","DOI":"10.1097\/MD.0000000000017565","article-title":"A case report of pelviscopic resection of invasive hydatidiform mole","volume":"98","author":"Lee","year":"2019","journal-title":"Medicine (Baltimore)."},{"key":"B14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11864-017-0502-0","article-title":"Fertility sparing strategies in patients affected by placental site trophoblastic tumor","volume":"18","author":"Chiofalo","year":"2017","journal-title":"Curr Treat Options Oncol."}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2021.798640\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T05:06:15Z","timestamp":1643346375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2021.798640\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":14,"alternative-id":["10.3389\/fsurg.2021.798640"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2021.798640","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"article-number":"798640"}}